logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10751392 B1

PDFFull Text
Date of Patent:
Aug. 25, 2020

Filed:

May. 27, 2016

Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonist

Applicant:

Immunoforge Co., Ltd., Gyeonggi-do, KR;

Inventors:

Hee Sook Jun, Incheon, KR;

Eun Young Park, Incheon, KR;

Yeon Hee Hong, Sejong, KR;

Assignee:

IMMUNOFORGE CO., LTD., Gyeonggi-Do, KR;

Attorney:

Knobbe, Martens, Olson & Bear LLP

Primary Examiner:

Gyan Chandra

Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 9/48 (2006.01); A61K 9/20 (2006.01); A61K 47/30 (2006.01); A61K 38/16 (2006.01); A61K 9/16 (2006.01); A61K 48/00 (2006.01); A61P 21/00 (2006.01); A61K 38/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 9/16 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 38/16 (2013.01); A61K 38/22 (2013.01); A61K 47/30 (2013.01); A61K 48/00 (2013.01); A61P 21/00 (2018.01);
Abstract

Provided are a pharmaceutical composition for preventing or treating muscle atrophy or sarcopenia including glucagon-like peptide-1 (GLP-1), a GLP-1 fragment, a GLP-1 secretion enhancer, a GLP-1 degradation inhibitor, a GLP-1 receptor (GLP-1R) agonist, or exendin-4, and a method of treating muscle atrophy or sarcopenia by using the pharmaceutical composition. When the pharmaceutical composition for preventing or treating muscle atrophy or sarcopenia provided in the present invention is administered to a subject having sarcopenia or muscle atrophy, reduced body weight, skeletal muscle mass, and grip strength, which are caused by sarcopenia or muscle atrophy, and expression levels of genes involved in muscle production may be restored to normal states, and therefore, the composition may be widely applied to the development of effective therapeutic agents for sarcopenia or muscle atrophy.

Find Patent Forward Citations

Jun, Hee. (2020). Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonist (U.S. Patent No. 10751392). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10751392

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…